LON:NIPTPremaitha Health Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Premaitha Health PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.57 million shsAverage Volume395,406 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInsider TradesHeadlines Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company is headquartered in Manchester, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Premaitha Health. Previous Next 2.4 Community Rank Outperform VotesPremaitha Health has received 249 “outperform” votes. (Add your “outperform” vote.)Underperform VotesPremaitha Health has received 275 “underperform” votes. (Add your “underperform” vote.)Community SentimentPremaitha Health has received 52.48% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Premaitha Health and other stocks. Vote “Outperform” if you believe NIPT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NIPT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldPremaitha Health does not currently pay a dividend.Dividend GrowthPremaitha Health does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Premaitha Health insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Medical Laboratories & Research Sub-IndustryN/A SectorMedical Current SymbolLON:NIPT Previous SymbolLON:VIY CUSIPN/A CIKN/A Webwww.premaitha.com Phone+44-161-6676865Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable 30 days | 90 days | 365 days | Advanced Chart Receive NIPT News and Ratings via Email Sign-up to receive the latest news and ratings for NIPT and its competitors with MarketBeat's FREE daily newsletter. Premaitha Health (LON:NIPT) Frequently Asked Questions How were Premaitha Health's earnings last quarter? Premaitha Health PLC (LON:NIPT) announced its earnings results on Friday, December, 29th. The company reported ($2.00) earnings per share (EPS) for the quarter. The business had revenue of $2.71 million for the quarter. View Premaitha Health's earnings history. Has Premaitha Health been receiving favorable news coverage? Headlines about NIPT stock have been trending extremely negative recently, according to InfoTrie. The research group rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Premaitha Health earned a media sentiment score of -4.6 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Premaitha Health. Who are some of Premaitha Health's key competitors? Some companies that are related to Premaitha Health include VolitionRX (VNRX), Spectral Medical (EDT), ANGLE (AGL), Proteome Sciences (PRM) and DiaSorin (DIA). View all competitors. What other stocks do shareholders of Premaitha Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Premaitha Health investors own include IQE (IQE), Avanti Communications Group (AVN), Chesapeake Utilities (CPK), Plethora Solutions (PLE), Vedanta Resources (VED), Mitie Group (MTO), Scancell (SCLP), Sirius Minerals (SXX), Advanced Micro Devices (AMD) and Aviva (AV). Who are Premaitha Health's key executives? Premaitha Health's management team includes the following people: Dr. Stephen Little, Exec. Vice Chairman (Age 61)Mr. Barry Hextall, CFO, Sec. & Exec. DirectorMr. Peter Collins, Chief Bus. Officer & Exec. Director (Age 59)Mr. Lyn Fafydd Rees, CEO & Director (Age 45)Dr. Chia-Han Chan, Chief Scientific Officer & Director (Age 42) What is Premaitha Health's stock symbol? Premaitha Health trades on the London Stock Exchange (LON) under the ticker symbol "NIPT." How do I buy shares of Premaitha Health? Shares of NIPT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Premaitha Health's official website? The official website for Premaitha Health is www.premaitha.com. How can I contact Premaitha Health? Premaitha Health's mailing address is Rutherford House, 40 Pencroft Way, MANCHESTER, M15 6SZ, United Kingdom. The company can be reached via phone at +44-161-6676865. This page was last updated on 8/6/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
